Scarica l'app Stockscreener
0.00
100.00%
-10.30
Apogee Acquisition Corp Borsa (AACPU) Ultime notizie
Apogee Therapeutics (NASDAQ: APGE) leaves Nasdaq in AbbVie cash buyout - Stock Titan
AbbVie-owned Apogee Therapeutics (APGE) pulls unsold stock - Stock Titan
Apogee Therapeutics (APGE) director-linked funds fully exit in AbbVie deal - Stock Titan
Apogee Therapeutics (APGE) CMO cashes out stock and options in AbbVie deal - Stock Titan
Director cashes out Apogee (NASDAQ: APGE) stake in AbbVie merger - Stock Titan
Apogee merger pays $135.11 per share in cash | APGE SEC FilingForm SCHEDULE 13D/A - Stock Titan
AbbVie Finalizes $10.9 Billion Acquisition of Apogee Therapeutics, Initiates Nasdaq Delisting - Kalkine Media
AbbVie Completes Acquisition of Apogee Therapeutics - Investing News Network
AbbVie Completes $10.9 Billion Acquisition of Apogee Therapeutics - Minichart
AbbVie Completes $10.9 Billion Apogee Acquisition, Reaffirms 2026 EPS Guidance - Minichart
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio - TipRanks
AbbVie seals $11B acquisition of Apogee Therapeutics (ABBV:NYSE) - seekingalpha.com
TOMI Regains Nasdaq Equity Compliance After $2.5M Debt Conversion - Minichart
Apogee Acquisition (AACP) Stock Chart and Price History 2026 - MarketBeat
ABBV climbs around 1.5% after double-digit revenue growth and Apogee acquisition - Traders Union
ARISTEIA CAPITAL, L.L.C. Initiates Position in Apogee Acquisitio - GuruFocus
Apogee Acquisition Corp Q2 2026: Net income $1.13M, EPS $0.08— 10-Q Summary - TradingView
Apogee Acquisition (AACP) faces 2027 deal-or-liquidation deadline - Stock Titan
Apogee Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
AbbVie Raises $10 Billion in Debt to Fund Apogee Acquisition - Minichart
AbbVie Completes $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Kalkine Media
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com
AbbVie (NYSE: ABBV) issues new senior notes with Apogee-linked redemption - Stock Titan
AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled - TradingKey
Apogee Acquisition (AACP) Stock Trends and Sentiment 2026 - MarketBeat
Apogee Acquisition Corp SEC Filing (Aug 14, 2026) - Stock Titan
Polar Asset Management (AACP) discloses 7.2% stake in Apogee Acquisition Corp - Stock Titan
Highbridge Capital Management (AACP) discloses 9.2% ownership of Apogee Acquisition - Stock Titan
Apogee Acquisition Corp (AACP) investors report 0% ownership in 13G/A exit - Stock Titan
Apogee Acquisition Corp (AACP) investor reports 7.05% holding in Class A shares - Stock Titan
Glazer Capital (AACP) discloses 5.45% Apogee Acquisition Corp stake in 13G - Stock Titan
Magnetar entities disclose 1.25M AACP shares on 13G, holding 7.05% stake - Stock Titan
Apogee Therapeutics Shareholders Endorse AbbVie Acquisition in Special Meeting - Kalkine Media
AbbVie agrees $10.9bn Apogee Therapeutics deal - Financier Worldwide
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? - Yahoo Finance
Apogee Therapeutics Reports Q2 2026 Results and Announces Merger Agreement with AbbVie Subsidiary - Kalkine Media
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion; Apogee Reports Positive Phase 2 Zumilokibart Data and Q2 2026 Results - Quiver Quantitative
Apogee's Atopic Dermatitis Drug Shows 65.9% EASI-75 - Stock Titan
AbbVie (ABBV) Announces $10 Billion Multi-Tranche Senior Notes O - GuruFocus
AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition, Bloomberg Reports - marketscreener.com
AbbVie Announces Multi-Tranche Senior Note Offering to Finance Apogee Therapeutics Acquisition - Kalkine Media
Equity in earnings of Apogee Acquisition Corp – NASDAQ:AACPW - TradingView
Upcoming & Recent IPO'sIPOs Calendar - finance.yahoo.com
Enterprise value to EBITDA forward of Apogee Acquisition Corp – NASDAQ:AACPR - TradingView
AbbVie Lowers Outlook to Account for Acquisition as Profit Jumps - WSJ
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc.APGE - Business Wire
AACP|Apogee Acquisition Ord Shs Class A|Price:9.997|Chg%:+0.007 - TradingKey
Apogee Acquisition Corp Revenue Breakdown – BOATS:AACPU - TradingView
Apogee Acquisition Corp Revenue Breakdown – NASDAQ:AACPR - TradingView
Apogee Acquisition Corp Revenue Breakdown – BOATS:AACPR - TradingView
Apogee Acquisition Corp Revenue Breakdown – NASDAQ:AACP - TradingView
Apogee Acquisition (AACPU) Stock Price, News & Analysis - MarketBeat
Price to sales forward of Apogee Acquisition Corp – BOATS:AACPW - TradingView
Enterprise value to EBIT forward of Apogee Acquisition Corp – BOATS:AACPW - TradingView
Price to earnings forward of Apogee Acquisition Corp – BOATS:AACPW - TradingView
Las Vegas firm to acquire bankrupt Kentucky distillery for $19.5M, report says - The Business Journals
How will AbbVie's $10.9 billion acquisition of Apogee impact its dividend? - MSN
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? - Yahoo Finance
Apogee Acquisition Sponsor Llc Net Worth (2026) - GuruFocus
Plugin Alliance, Brainworx Re-Acquired by Founder Dirk Ulrich - Mixonline
Apogee Minerals Ltd. - Via Ritzau
Apogee Minerals Enters into Option Agreement to Acquire a 100% Interest in the Knife Lake Copper Project in Saskatchewan from Trident Resources - Junior Mining Network
Apogee Therapeutics (NASDAQ: APGE) backs AbbVie’s $135.11‑per‑share all‑cash deal - Stock Titan
Price to book forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Enterprise value to revenue forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Acquisition Corp Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Apogee Acquisition Corp Rings the Closing Bell - Nasdaq
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):